Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation.
| Author | |
|---|---|
| Year of Publication |
:
2018
|
| Journal |
:
Gut
|
| Date Published |
:
2018
|
| ISSN Number |
:
0017-5749
|
| URL |
:
http://gut.bmj.com/cgi/pmidlookup?view=long&pmid=29331941
|
| DOI |
:
10.1136/gutjnl-2017-315766
|
| Short Title |
:
Gut
|
| Download citation |
